Please login to the form below

Not currently logged in
Email:
Password:

Frank Pieters leaves Teva to lead Cipla’s respiratory business

Will head up attempt to capitalise on the expiry of major pharma patents, such as that of GSK's Advair

Frank Pieters has left Teva Pharmaceutical to join India-based generics company Cipla as head of its European region and global respiratory business.

Pieters was most recently senior VP Southern Europe at Israel-based Teva – the largest generics company in the world.

His latest move signals an intent from Cipla to take advantage of the patent expiries for leading respiratory products, including GlaxoSmithKline’s (GSK) Advair, which Cipla has a generic version.

“With [Pieters] at the helm, Cipla would like to capture the huge commercial upside of 30 years experience in Cipla’s respiratory medicine; both in emerging and regulated markets,” said Dr Yusuf Hamied, chairman and managing director, Cipla.

“This appointment signals Cipla’s strengthening of senior management positions and also illustrates Cipla’s desire for senior on-ground talent in overseas markets to build its product portfolio and brand.”

During his time at Teva, Pieters also served as senior VP global biogenerics and global respiratory commercial business and he was also a member of the TEVA-Lonza Joint Steering Committee.

From 1989 to 2004, he held several senior positions at GSK, including VP and general manager.

Contact:

Phone:

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Chandler Chicco Agency

Chandler Chicco Agency (CCA) - CCC's flagship brand, is the world's largest pure-play healthcare public relations firm with a long-standing...

Latest intelligence

McCann.jpg
The heart of the matter: Part Two
How is social media impacting publication planning?...
digital numbers
Seven steps to innovating your digital strategy
Dealing with digitally native HCPs...
Online Physician Communities
Online learning increasingly popular for doctors
Sponsorship can help companies raise their profile specific therapy areas...